Kawai Masanobu, Namba Noriyuki, Mushiake Sotaro, Etani Yuri, Nishimura Riko, Makishima Makoto, Ozono Keiichi
Department of Pediatrics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
J Mol Endocrinol. 2007 Feb;38(1-2):19-34. doi: 10.1677/jme.1.02154.
Growth hormone-deficient (GHD) patients show a decreased number of adipocytes, which is normalized by GH replacement, indicating an adipogenic effect of GH. However, the precise mechanisms underlying this effect remain to be clarified. In this study, we investigated the adipogenic effect of GH. GH stimulated MDI (3-isobutyl-1-methylxanthine, dexamethasone, and insulin)-induced adipogenesis of 3T3-L1 cells with early induction of peroxisome proliferator-activated receptors (PPAR)gamma2 expression. This adipogenic effect of GH was suppressed by overexpression of Stat5A mutant (Stat5A-Y694F), a transcriptional suppressor for the GH-Stat5A/5B signaling pathway, with the reduction of PPARgamma2 expression. Next, we investigated the relationship between Stat5A/5B and CCAAT/enhancer binding protein (C/EBP)beta/delta orPPARgamma in 3T3-L1 cells. Stat5A/5B stimulated C/EBPbeta- and C/EBPdelta-induced adipogenesis with enhancement of PPARgamma2 expression. In addition, Stat5A/5B enhanced the transcriptional activity of C/EBPbeta/delta in the PPARgamma gene promoter. Furthermore, Stat5A/5B stimulated PPARgamma-induced adipogenesis and enhanced the transcriptional activity of PPARgamma. These results suggest that the GH-Stat5A/5B signaling pathway stimulates adipogenesis in cooperation with C/EBPbeta/delta and PPARgamma. To completely understand the effect of GH, cDNA microarray analysis was performed to screen genes affected by GH during MDI-induced adipogenesis. Among 4277 genes, 18 and 19 genes were up- and down-regulated respectively. cDNA microarray analysis also indicated the up-regulation of PPARgamma and the modulation of expression of genes coding for growth factors or growth factor receptors, suggesting that GH stimulates adipogenesis in association with the modulation of cell growth. Thus, the GH-Stat5A/B signaling pathway stimulates adipogenesis through two distinct steps. In addition, cDNA microarray data provide us the further insights underlying the adipogenic effect of GH.
生长激素缺乏(GHD)患者的脂肪细胞数量减少,通过生长激素替代可使其恢复正常,这表明生长激素具有促脂肪生成作用。然而,这种作用的具体机制仍有待阐明。在本研究中,我们探究了生长激素的促脂肪生成作用。生长激素刺激3T3-L1细胞在MDI(3-异丁基-1-甲基黄嘌呤、地塞米松和胰岛素)诱导下的脂肪生成,并早期诱导过氧化物酶体增殖物激活受体(PPAR)γ2表达。生长激素的这种促脂肪生成作用被Stat5A突变体(Stat5A-Y694F)过表达所抑制,Stat5A-Y694F是生长激素-Stat5A/5B信号通路的转录抑制因子,同时PPARγ2表达降低。接下来,我们研究了3T3-L1细胞中Stat5A/5B与CCAAT/增强子结合蛋白(C/EBP)β/δ或PPARγ之间的关系。Stat5A/5B刺激C/EBPβ和C/EBPδ诱导的脂肪生成,并增强PPARγ2表达。此外,Stat5A/5B增强了PPARγ基因启动子中C/EBPβ/δ的转录活性。此外,Stat5A/5B刺激PPARγ诱导的脂肪生成并增强PPARγ的转录活性。这些结果表明,生长激素-Stat5A/5B信号通路与C/EBPβ/δ和PPARγ协同刺激脂肪生成。为了全面了解生长激素的作用,我们进行了cDNA微阵列分析,以筛选在MDI诱导的脂肪生成过程中受生长激素影响的基因。在4277个基因中,分别有18个和19个基因上调和下调。cDNA微阵列分析还表明PPARγ上调以及编码生长因子或生长因子受体的基因表达受到调节,这表明生长激素与细胞生长调节相关联刺激脂肪生成。因此,生长激素-Stat5A/B信号通路通过两个不同步骤刺激脂肪生成。此外,cDNA微阵列数据为我们提供了关于生长激素促脂肪生成作用的进一步见解。